|
Clinical characteristics of enrolled subjects with confirmed ASB and sterile urine (N = 248)* |
||
| Clinical characteristics |
Confirmed ASB N = 14 |
Sterile urine N = 234 |
|
|
||
| Age yr |
27.9 ± 2.3 |
26.4 ± 2.5 |
| †Gender (M:F) |
1:13 |
124:110 |
| #Genotype frequency (HbSS:HbSC:HbSβ0:HbSβ+: sickle variants) |
9:2:1:2:0 |
130:75:5:19:5 |
| Creatinine μmol/L |
49.1 ± 12.4 |
53.7 ± 14.3 |
| Uric Acid mmol/L |
0.36 ± 0.29 |
0.33 ± 0.08 |
| †Proteinuria ≥ trace : No proteinuria (n = 168) |
1:7 |
22 :138 |
| †Positive History of gram negative sepsis |
1 |
1 |
| †Positive recorded history of ever having UTI |
7 |
25 |
| †Cumulative number of recorded clinic visits for symptomatic UTI* |
18 |
49 |
|
*Values of subjects with probable ASB excluded from table. † Values are counts. Abbreviations : ASB = asymptomatic bacteriuria; HbSC= Sickle cell-haemoglobin C, HbSβ0 = Sickle cell-β0 thalassemia, HbSβ+ = Sickle cell-β+ thalassemia; UTI = Urinary Tract Infections #Sickle variants include sickle cell-hereditary persistence of foetal haemoglobin, sickle cell -haemoglobin O Arab, sickle cell -haemoglobin Lepore-Boston; | ||
Cumming et al. BMC Infectious Diseases 2006 6:46 doi:10.1186/1471-2334-6-46 |
||